Advertisement

Supply Chain

STAT spoke with pharmaceutical insiders, physicians, Wall Street analysts and FDA veterans about the potential benefits and consequences of President Donald Trump's plan to deregulate the FDA and speed up the approval process for drugs and devices.

Bard Peripheral Vascular issued a voluntary recall of its Halo One Thin-Walled Guiding Sheath over structural issues with the device, according to a Food and Drug Administration report.

Group purchasing organizations reduce healthcare costs, increase competition and drive transparency, among other advantages, according to a new report from the Healthcare Supply Chain Association.

Advertisement

President Trump, with guidance from his technology advisor Peter Thiel, has identified numerous candidates to head the Food and Drug Administration, many of whom come from a technology background. In an article for Vox, writer Julia Belluz highlights the dangers…

Eight democrats on the Senate health committee are urging President Donald Trump's administration to provide answers for how the federal hiring freeze will affect the Food and Drug Administration, reports STAT.

Advertisement